Prevention of acute rejection after rescue with Belatacept by association of low-dose Tacrolimus maintenance in medically complex kidney transplant recipients with early or late graft dysfunction
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevention of acute rejection after rescue with Belatacept by association of low-dose Tacrolimus maintenance in medically complex kidney transplant recipients with early or late graft dysfunction
Authors
Keywords
Renal transplantation, Medical risk factors, Liver transplantation, Kidneys, Immunosuppressives, Medical dialysis, Organ transplantation, Transplantation immunology
Journal
PLoS One
Volume 15, Issue 10, Pages e0240335
Publisher
Public Library of Science (PLoS)
Online
2020-10-16
DOI
10.1371/journal.pone.0240335
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Conversion to belatacept within 1‐year of renal transplantation in a diverse cohort including patients with donor specific antibodies
- (2020) Andrew D. Santeusanio et al. CLINICAL TRANSPLANTATION
- Avoidance of CNI and steroids using belatacept—Results of the Clinical Trials in Organ Transplantation 16 trial
- (2020) Roslyn B. Mannon et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Switching renal transplant recipients to belatacept therapy: results of a real-life gradual conversion protocol
- (2019) Paolo Malvezzi et al. TRANSPLANT IMMUNOLOGY
- Validation of the Kidney Donor Profile Index (KDPI) to assess a deceased donor’s kidneys’ outcome in a European cohort
- (2019) Maximilian Dahmen et al. Scientific Reports
- Opportunistic infections after conversion to belatacept in kidney transplantation
- (2019) Dominique Bertrand et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients administered belatacept or cyclosporine in BENEFIT and BENEFIT-EXT
- (2018) Sander Florman et al. CLINICAL TRANSPLANTATION
- Conversion to belatacept in maintenance kidney-transplant patients
- (2018) Amandine Darres et al. TRANSPLANTATION
- Belatacept in Solid Organ Transplant
- (2018) Caroline P. Perez et al. TRANSPLANTATION
- Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR)
- (2018) Claire Leibler et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Belatacept Compared With Tacrolimus for Kidney Transplantation
- (2017) Jordana B. Cohen et al. TRANSPLANTATION
- A Randomized Controlled Clinical Trial Comparing Belatacept With Tacrolimus After De Novo Kidney Transplantation
- (2017) Gretchen N. de Graav et al. TRANSPLANTATION
- Late Conversion to Belatacept After Kidney Transplantation: Outcome and Prognostic Factors
- (2017) M. Dürr et al. TRANSPLANTATION PROCEEDINGS
- Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients
- (2016) X. Wen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Effect of an Early Switch to Belatacept Among Calcineurin Inhibitor-Intolerant Graft Recipients of Kidneys From Extended-Criteria Donors
- (2016) Y. Le Meur et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Belatacept and Long-Term Outcomes in Kidney Transplantation
- (2016) Flavio Vincenti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Experience with belatacept rescue therapy in kidney transplant recipients
- (2016) Susanne Brakemeier et al. TRANSPLANT INTERNATIONAL
- Costimulation Blockade in Kidney Transplantation
- (2016) Paolo Malvezzi et al. TRANSPLANTATION
- Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction
- (2015) G. Gupta et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Belatacept-Based Immunosuppression inDe NovoLiver Transplant Recipients: 1-Year Experience From a Phase II Randomized Study
- (2014) G. B. Klintmalm et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long-Term Extension of the BENEFIT Study
- (2013) L. Rostaing et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients
- (2011) F. Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes
- (2011) M. Tonelli et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Conversion of Long-Term Kidney Transplant Recipients From Calcineurin Inhibitor Therapy to Everolimus: A Randomized, Multicenter, 24-Month Study
- (2011) Hallvard Holdaas et al. TRANSPLANTATION
- A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
- (2010) F. Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now